Relypsa Obtains $12,734,652 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=753be57d-dde0-4877-be6e-89a9462014ed&Preview=1
Date
10/8/2012
Company Name
Relypsa
Mailing Address
5301 Patrick Henry Drive Santa Clara, CA 95054
Company Description
Relypsa, Inc. is a biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and cardiovascular disease.
Website
http://www.relypsa.com
Transaction Type
Venture Equity
Transaction Amount
$12,734,652
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing-amended.
M&A Terms
Venture Investor
Undisclosed